Menu
GeneBe

ASB1

ankyrin repeat and SOCS box containing 1, the group of Ankyrin repeat domain containing

Basic information

Region (hg38): 2:238426741-238452250

Links

ENSG00000065802NCBI:51665OMIM:605758HGNC:16011Uniprot:Q9Y576AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ASB1 gene.

  • Inborn genetic diseases (9 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ASB1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
9
clinvar
9
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 9 0 0

Variants in ASB1

This is a list of pathogenic ClinVar variants found in the ASB1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-238427086-A-G not specified Uncertain significance (Jan 04, 2024)3130067
2-238427096-G-A not specified Uncertain significance (Mar 07, 2023)3130068
2-238427096-G-C not specified Uncertain significance (Oct 06, 2023)3130069
2-238433599-C-T not specified Uncertain significance (Feb 16, 2023)2466620
2-238433623-G-A not specified Uncertain significance (Dec 12, 2023)3130066
2-238433692-G-A not specified Uncertain significance (Aug 14, 2023)2603216
2-238435815-G-A not specified Uncertain significance (Nov 18, 2022)2327717
2-238435949-C-T not specified Uncertain significance (Aug 02, 2022)2305088
2-238444395-G-C not specified Likely benign (Oct 25, 2023)3130070
2-238444455-A-G not specified Uncertain significance (Jan 16, 2024)3130071
2-238444494-C-T not specified Uncertain significance (May 31, 2022)2204842
2-238444580-C-T not specified Uncertain significance (Dec 15, 2022)3130072
2-238444634-C-G not specified Uncertain significance (Nov 07, 2022)2323131
2-238444695-C-T not specified Uncertain significance (Nov 21, 2023)3130073
2-238446414-G-A not specified Uncertain significance (Nov 14, 2023)3130074
2-238446447-G-A not specified Uncertain significance (Dec 03, 2021)2403448
2-238446458-A-G not specified Uncertain significance (Mar 07, 2023)2495398
2-238446465-C-T not specified Uncertain significance (Apr 22, 2022)2395403

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ASB1protein_codingprotein_codingENST00000264607 525509
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.002990.9491257270211257480.0000835
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.271602120.7550.00001412148
Missense in Polyphen76111.460.681841052
Synonymous-0.4279690.81.060.00000606723
Loss of Function1.72612.60.4766.85e-7138

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001490.000149
Ashkenazi Jewish0.00009950.0000992
East Asian0.0001630.000109
Finnish0.000.00
European (Non-Finnish)0.00007050.0000703
Middle Eastern0.0001630.000109
South Asian0.0001960.000196
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: May play a role in testis development (By similarity). Probable substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. {ECO:0000250, ECO:0000269|PubMed:16325183}.;
Pathway
Post-translational protein modification;Metabolism of proteins;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Neddylation (Consensus)

Recessive Scores

pRec
0.110

Intolerance Scores

loftool
0.345
rvis_EVS
-0.52
rvis_percentile_EVS
21.2

Haploinsufficiency Scores

pHI
0.241
hipred
Y
hipred_score
0.757
ghis
0.674

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.838

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Asb1
Phenotype
endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); immune system phenotype; hematopoietic system phenotype; reproductive system phenotype;

Gene ontology

Biological process
protein ubiquitination;male genitalia development;intracellular signal transduction;negative regulation of cytokine biosynthetic process;post-translational protein modification
Cellular component
ubiquitin ligase complex;cytosol
Molecular function
protein binding;ubiquitin protein ligase activity